P2RY12 and atherosclerosis: Although none of these studies used standard whole aorta en face atherosclerosis assays to quantify the extent of atherosclerosis, their data suggest that both CLO and TIC, which are P2Y12 antagonists, inhibit the progression of atherosclerosis without ASA.